This educational activity is designed to provide our faculty with alternative sources of information and experience on controversial areas in diagnostic pathology that cannot be gleaned from reading the literature or standard textbooks in pathology. There are many areas in pathology where a uniformly acceptable standard has not yet been established. Direct interaction with an expert can provide the pathologist with additional insight into more effective ways to handle the issue.
At the conclusion of this activity, learners will be able to:
Discuss the role of constitutively active androgen receptor splicing variants in castration resistant prostate cancer development
Describe the potential clinical use of AR-V7 as a molecular marker to guide treatment decision in castration resistant prostate cancer
Explain translational studies exploring AR-V7 in salivary duct carcinoma
Rong Hu, MD, PhD
Department of Pathology & Laboratory Medicine
University of Wisconsin-Madison
All persons in control of content have NO relevant financial relationships to disclose except the following:
|Rong Hu, MD, PhD||Qiagen||Licensed IP|
|Rong Hu, MD, PhD||A&G Pharma||Licensed IP|
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.